What should be done after accidental ingestion of a salbutamol (albuterol) nebuliser solution containing 2.5 mg in 2.5 mL?

Accidental Ingestion of Salbutamol Nebule: Management

For accidental ingestion of a 2.5mg salbutamol nebule solution, most children can be safely observed at home without intervention if the dose is ≤0.6 mg/kg, while larger ingestions (>0.6 mg/kg) warrant direct medical evaluation with gastrointestinal decontamination and monitoring for transient cardiovascular and metabolic effects.

Immediate Assessment

Calculate the dose per kilogram:

• 2.5 mg salbutamol ingested ÷ child's weight in kg = mg/kg dose
• This determines the management pathway

Management Based on Dose

Low-Dose Ingestion (≤0.6 mg/kg)

• Home observation is sufficient 1
• No intervention required in most cases
• Parents should monitor for symptoms over 4-6 hours
• Expected outcome: asymptomatic in vast majority

Moderate-to-High Dose Ingestion (>0.6 mg/kg)

• Direct medical evaluation recommended 1, 2
• Consider gastrointestinal decontamination with activated charcoal if presenting within 1-2 hours
• Monitor for 6-12 hours in emergency department setting

Expected Clinical Effects

The threshold for developing three or more signs of toxicity is 1 mg/kg 2. Common findings include:

Cardiovascular (most common):

• Sinus tachycardia (57% of cases) 2
• Widened pulse pressure (50% of cases) 2

Metabolic:

• Hypokalemia (26-100% depending on dose) - can be significant (as low as 2.3-2.8 mmol/L) 3, 4
• Hyperglycemia (50% of cases) 2
• Low serum CO₂ (42% of cases) 2

Neuromuscular:

• Agitation/irritability (45% of cases) 2
• Tremors (less common) 1
• Vomiting (26% of cases) 2

Monitoring and Treatment

If medical evaluation is pursued:

1. Obtain baseline labs (especially if dose >1 mg/kg):

   • Serum potassium (priority)
   • Blood glucose
   • Serum CO₂/bicarbonate
   • ECG if significant tachycardia or hypokalemia present 3, 4

2. Supportive care only:

   • Intravenous potassium replacement if hypokalemia is significant 3, 4
   • Monitor blood glucose
   • Serial ECGs if hypokalemia present 4
   • Intravenous hydration as needed

3. No specific antidote exists - all effects are transient and self-limiting 1, 2

Reassuring Points

Critical safety data from multiple studies:

• No serious cardiac events requiring withdrawal from studies 1, 2
• No deaths reported in pediatric ingestion series 1, 2
• 72% of patients discharged within 6 hours 2
• All patients recovered uneventfully within 12-24 hours with supportive care only 3
• Effects are short-lived and benign despite appearing dramatic 2

Common Pitfall to Avoid

Do not confuse oral ingestion with therapeutic inhalation dosing. The nebule solution is designed for inhalation, not oral administration. When ingested orally, it does not improve respiratory symptoms and only causes systemic side effects 4. The FDA-approved therapeutic dose is 2.5 mg administered via nebulization over 5-15 minutes 5, which results in much lower systemic absorption than oral ingestion of the same amount.

Duration of Observation

• Minimum 6 hours for symptomatic patients 2
• Up to 12-24 hours if significant hypokalemia or persistent tachycardia 3
• Most metabolic abnormalities resolve within this timeframe

Hospital admission is rarely required unless complications develop or the child has significant comorbidities 2.